- Report
- August 2022
United States
From €1777EUR$1,940USD£1,514GBP
- Report
- August 2021
Global
From €3654EUR$3,990USD£3,113GBP
- Report
- August 2021
Europe
From €3132EUR$3,420USD£2,668GBP
- Report
- May 2021
- 62 Pages
Global
€1207EUR$1,318USD£1,028GBP
- Report
- November 2020
- 199 Pages
Global
€4121EUR$4,500USD£3,511GBP
- Report
- January 2025
- 101 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- February 2024
- 107 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- October 2023
- 110 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- November 2023
- 113 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- May 2023
- 97 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- May 2023
- 89 Pages
Global
From €3500EUR$4,094USD£3,086GBP
- Report
- June 2022
- 292 Pages
Global
From €2290EUR$2,500USD£1,950GBP
- Report
- January 2025
- 132 Pages
Global
From €870EUR$950USD£741GBP
- Report
- September 2023
- 235 Pages
Global
From €2289EUR$2,499USD£1,950GBP
€3269EUR$3,570USD£2,785GBP

The Dry Eye Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat a variety of eye conditions. Dry Eye Drugs are used to treat the symptoms of dry eye syndrome, a condition in which the eyes do not produce enough tears or the tears evaporate too quickly. These drugs can be administered topically, orally, or through injection. Commonly used Dry Eye Drugs include artificial tears, anti-inflammatory medications, and immunomodulators.
Some companies in the Dry Eye Drug market include Allergan, Bausch + Lomb, Santen Pharmaceuticals, Shire, and Sun Pharmaceuticals. Show Less Read more